Stephen Broderick, MD, MPHS

Associate Professor of Surgery
Johns Hopkins Medical Institutions
Baltimore, Maryland, United States

Dr Stephen R Broderick MD, MPHS is an Associate Professor in the Division of Thoracic Surgery at Johns Hopkins where he leads the leads the clinical program in the National Capital Region and serves as Division Director for Quality and Patient Safety. His clinical and research interests are focused around the coordinated multidisciplinary care of patients with thoracic malignancies. Specifically, he has contributed to multiple clinical trials evaluating the role of neoadjuvant immune checkpoint inhibition in patients with resectable non-small cell lung cancer. Dr Broderick also serves on the Society of Thoracic Surgeons General Thoracic Surgery Database Task Force and the Staging and Prognostic Factors Workgroup of the International Association for the Study of Lung Cancer.

Disclosure information not submitted.

Presentation(s):

• Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice

  Saturday, January 25, 2025
  5:45pm – 6:45pm PT

• When to Refer for Neoadjuvant

  Sunday, January 26, 2025
  10:15am – 10:27am PT